Covid and JNJ Q4 2021 earnings

Read Time:2 Minute, 19 Second


Janssen Johnson & Johnson’s COVID-19 vaccine.

Alan J. Cockroach | Los Angeles Times | Getty Images

Johnson & Johnson on Tuesday expected its Covid vaccine to generate $3 billion to $3.5 billion in sales in 2022, after the company released a mixed fourth-quarter report that slightly beat earnings estimates but missed revenue expected.

Here’s how they fared compared to Wall Street expectations, according to average analyst estimates compiled by Refinitiv:

  • Adjusted EPS: $2.13 compared to expectations of $2.12.
  • income: $24.8 billion vs. $25.29 billion expected

CFO Joseph Volcker told CNBC that the stronger dollar had a negative impact of $150 million to $200 million on top-line sales. Hospital staffing shortages caused by the omicron Covid variant also created uncertainty for the company’s medical device business, particularly in elective surgery, Wolk said. He added that the consumer health sector has been hit by raw material supply constraints, labor shortages at third-party manufacturers and rising transportation costs.

“We think the second half of 2022 will be stronger than the first half,” Volcker told CNBC’s Meg Tirrell on “Squawk Box.” “But some of those dynamics continued at the beginning of the year.”

Johnson & Johnson reported sales of $93.77 billion in 2021, up 13.6% from the previous year. The company’s pharmaceutical division achieved revenue of US$52.08 billion, a year-on-year increase of 14.3%. Johnson & Johnson’s medical device business generated sales of $27.06 in 2021, an increase of 17.9% over 2020. Revenue in the Consumer Health segment was $14.63 billion, up 4.1%.

Johnson & Johnson said it expects earnings of $10.40 to $10.60 per share this year on revenue of $98.9 billion to $100.4 billion.

CEO Joaquin Duato will lead the earnings call for the first time in his new role at Johnson & Johnson this morning. Earlier this month, Duato officially replaced Alex Gorsky.

The fourth-quarter results marked the end of a difficult year for J&J. Public confidence in the company’s single-shot Covid vaccine took a hit in December when the Centers for Disease Control and Prevention recommended vaccines from Pfizer and Moderna over Johnson & Johnson’s. The CDC found that dozens of people, mostly young women, developed a rare blood clot condition after receiving Johnson & Johnson’s vaccine.

In June, J&J asked the Supreme Court to review a $2.1 billion lower court appeal against women who claimed asbestos in the company’s talc caused ovarian cancer.

J&J also separated its consumer products business from its pharmaceutical and medical device businesses, creating two publicly traded companies. Johnson & Johnson expects to close the deal by the end of 2023.


If you want to know more about business please go to https://updatednews24.com/category/business/

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Accept
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active

Who we are

Suggested text: Our website address is: https://updatednews24.com.

Comments

Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.

Media

Suggested text: If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.

Cookies

Suggested text: If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed. If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Suggested text: Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website. These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.

Who we share your data with

Suggested text: If you request a password reset, your IP address will be included in the reset email.

How long we retain your data

Suggested text: If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.

What rights you have over your data

Suggested text: If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.

Where we send your data

Suggested text: Visitor comments may be checked through an automated spam detection service.
Save settings
Cookies settings